222 related articles for article (PubMed ID: 1694911)
1. Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue.
Schwinger RH; Böhm M; Erdmann E
J Cardiovasc Pharmacol; 1990 Jun; 15(6):892-9. PubMed ID: 1694911
[TBL] [Abstract][Full Text] [Related]
2. Different negative inotropic activity of Ca2(+)-antagonists in human myocardial tissue.
Schwinger RH; Böhm M; Erdmann E
Klin Wochenschr; 1990 Aug; 68(16):797-805. PubMed ID: 2145465
[TBL] [Abstract][Full Text] [Related]
3. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
Schwinger RH; Böhm M; Erdmann E
Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
[TBL] [Abstract][Full Text] [Related]
4. Effects of hypoxia, elevated K+ and acidosis on the potency of verapamil, diltiazem and nifedipine in the guinea-pig isolated papillary muscle.
Robertson MJ; Lumley P
Br J Pharmacol; 1989 Nov; 98(3):937-49. PubMed ID: 2590774
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
[TBL] [Abstract][Full Text] [Related]
6. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
Ishii K; Taira N; Yanagisawa T
Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel T-type calcium channel antagonist mibefradil on human myocardial contractility in comparison with nifedipine and verapamil.
Cremers B; Flesch M; Südkamp M; Böhm M
J Cardiovasc Pharmacol; 1997 May; 29(5):692-6. PubMed ID: 9213214
[TBL] [Abstract][Full Text] [Related]
8. Differential potentiation by depolarization of the effects of calcium antagonists on contraction and Ca2+ current in guinea-pig heart.
Okuyama R; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1994 Oct; 113(2):451-6. PubMed ID: 7834195
[TBL] [Abstract][Full Text] [Related]
9. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
10. Relative selectivity for negative chronotropic and inotropic effects of a novel dihydropyridine derivative CD-832.
Noguchi K; Masumiya H; Sasaki T; Takahashi K; Araki H; Higuchi S; Tanaka H; Shigenobu K
Eur J Pharmacol; 1996 Jul; 308(1):53-9. PubMed ID: 8836632
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
[TBL] [Abstract][Full Text] [Related]
12. The preferential inhibition of alpha 1- over beta-adrenoceptor-mediated positive inotropic effect by organic calcium antagonists in the rabbit papillary muscle.
Kushida H; Hiramoto T; Endoh M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):206-14. PubMed ID: 2160615
[TBL] [Abstract][Full Text] [Related]
13. Myocardial and vascular effects of efonidipine in vitro as compared with nifedipine, verapamil and diltiazem.
Tanaka H; Masumiya H; Sekine T; Sijuku T; Sugahara M; Taniguchi H; Terada M; Saito W; Shigenobu K
Gen Pharmacol; 1996 Apr; 27(3):451-4. PubMed ID: 8723524
[TBL] [Abstract][Full Text] [Related]
14. Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.
Hugtenburg JG; Mathy MJ; Boddeke HW; Beckeringh JJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):567-75. PubMed ID: 2615848
[TBL] [Abstract][Full Text] [Related]
15. Calcium-channel blocking agents.
Leonard RG; Talbert RL
Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
[TBL] [Abstract][Full Text] [Related]
16. The relative sensitization by acidosis of five calcium blockers in cat papillary muscles.
Smith HJ; Briscoe MG
J Mol Cell Cardiol; 1985 Jul; 17(7):709-16. PubMed ID: 4020884
[TBL] [Abstract][Full Text] [Related]
17. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
Nishimura K; Miyawaki N; Yamauchi H; Iso T
Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
[TBL] [Abstract][Full Text] [Related]
18. Reflex chronotropic and inotropic effects of calcium channel-blocking agents in conscious dogs. Diltiazem, verapamil, and nifedipine compared.
Nakaya H; Schwartz A; Millard RW
Circ Res; 1983 Mar; 52(3):302-11. PubMed ID: 6825222
[TBL] [Abstract][Full Text] [Related]
19. The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
Hugtenburg JG; Mathy MJ; Beckeringh JJ; van Zwieten PA
Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):558-66. PubMed ID: 2615847
[TBL] [Abstract][Full Text] [Related]
20. Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.
Hattori Y; Hazama S; Kanno M; Nakao Y
Br J Pharmacol; 1986 Feb; 87(2):299-305. PubMed ID: 2420406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
